亚宝药业: 亚宝药业集团股份有限公司通知债权人公告

Group 1 - The company announced a share repurchase plan with a total fund amount between RMB 50 million and RMB 100 million, with a maximum repurchase price of RMB 6.95 per share [2] - The estimated number of shares to be repurchased ranges from 7,194,244 shares, accounting for 1.03% of the total share capital, based on the lower limit of the repurchase amount [2] - The repurchased shares will be fully canceled and will reduce the company's registered capital after the completion of the buyback [2] Group 2 - Creditors are informed that they can request the company to settle debts or provide corresponding guarantees after receiving the notice [2] - Creditors who fail to declare their claims within the specified period will not affect the validity of their claims, and the company will continue to fulfill its obligations according to the original debt documents [2] - Creditors can submit their claims through on-site, mail, or fax methods, with specific instructions provided for each submission method [2]